| Training group | Validation group | χ2/t | P |
---|---|---|---|---|
Age, years | 59.4 ± 13.0 | 59.4 ± 13.59 | 0.017 | 0.986 |
Sex | Â | Â | 0.097 | 0.755 |
 Male | 167 | 67 |  |  |
 Female | 76 | 33 |  |  |
Tumor Grade | Â | Â | 4.302 | 0.352 |
 I | 32 | 21 |  |  |
 II | 117 | 44 |  |  |
 III | 83 | 29 |  |  |
 IV | 8 | 4 |  |  |
 Unknow | 3 | 2 |  |  |
T stage | Â | Â | 0.600 | 0.985 |
 I | 121 | 48 |  |  |
 II | 58 | 26 |  |  |
 III | 53 | 21 |  |  |
 IV | 9 | 4 |  |  |
 Unknow | 2 | 1 |  |  |
N stage | Â | Â | 1.214 | 0.546 |
 N0 | 172 | 68 |  |  |
 N1 | 3 | 0 |  |  |
 Unknow | 68 | 32 |  |  |
M stage | Â | Â | 3.121 | 0.176 |
 M0 | 180 | 65 |  |  |
 M1 | 2 | 1 |  |  |
 Unknow | 61 | 34 |  |  |
TNM stage | Â | Â | 8.088 | 0.076 |
 I | 117 | 45 |  |  |
 II | 56 | 21 |  |  |
 III | 59 | 21 |  |  |
 IV | 2 | 1 |  |  |
 Unknow | 9 | 12 |  |  |